- Poster presentation
- Open Access
Neuroprotective effect of a new synthetic aspirin-decursinol adduct in a rat model of ischemic stroke
Critical Care volume 17, Article number: P345 (2013)
Stroke is a major cause of death. This study investigated the preventative effect of a new synthetic drug on brain function in experimentally induced ischemic stroke.
Male Sprague-Dawley rats were administered aspirin (ASA), decursinol (DA) or ASA-DA before and after ischemic insults. Brain and neuronal damage were examined by TTC staining, PEP-CT, NeuN immunohistochemistry and F-J B histofluorescence. Gliosis was also observed by GFAP and iba-1 immunohistochemistry.
Pretreatment with 20 mg/kg, but not 10 mg/kg, of ASA-DA protected against ischemic neuronal death and damage, and its neuroprotective effect was much more pronounced than that of ASA or DA alone. In addition, treatment with 20 mg/kg ASA-DA reduced the ischemia-induced activation of astrocytes and microglia.
Our findings indicate that ASA-DA, a new synthetic drug, prevents against transient focal cerebral ischemia, which provides a resource for the development of its clinical application for stroke.
About this article
Cite this article
Lee, Y., Park, C., Cho, J. et al. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in a rat model of ischemic stroke. Crit Care 17, P345 (2013). https://doi.org/10.1186/cc12283
- Ischemic Stroke
- Cerebral Ischemia
- Neuroprotective Effect